Skip to main content

lacosamide (Vimpat®)

 

Status: In progress

Adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in children from 2 years of age < 4 years of age with epilepsy.

Medicine details

Medicine name lacosamide (Vimpat®)
Formulation 50 mg, 100 mg, 150 mg, 200 mg film-coated tablets; 10 mg/ml oral solution; 200 mg/20 ml solution for infusion
Reference number 4698
Indication

As above

Company UCB Pharma Ltd
BNF chapter Central nervous system
Submission type Licence extension for paediatric use
Status In progress
AWMSG meeting date TBC
Date of issue TBC
Follow AWTTC: